MedTrace Logo

The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population

NCT00766558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2017-06-20

No results posted yet for this study

Summary

A technique that has been found to be effective at relieving the physical and psychological symptoms associated with inhibiting emotions and emotional thoughts is written emotional disclosure. The goal of this study is to evaluate the effectiveness of written emotional disclosure on the remediation of eating disorder behaviour, cognitions, and management of emotions.

Conditions

  • Anorexia Nervosa
  • Bulimia Nervosa
  • Eating Disorder

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Richard L Levine, MD · Penn State College of Medicine

Eligibility

Min Age
14 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-06-30
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766558 on ClinicalTrials.gov